Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis
- PMID: 7678717
- PMCID: PMC1886837
Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis
Abstract
In antibody-mediated glomerular disease, deposits of C3 (C3b) are common and are degraded by factor I to C3c and C3d. However, the kinetics of C3b degradation in glomerulonephritis have not been defined. To do this, we studied three models of complement-dependent glomerulonephritis with established C3 deposits (passive Heymann nephritis, cationized immunoglobulin G membranous nephropathy, and concanavalin A-anticoncanavalin A glomerulonephritis). C3b deposition was halted by administration of cobra venom factor, and the disappearance of C3c and C3d from glomeruli was measured with specific antibodies and quantitative fluorescence densitometry. Results showed that C3c deposits were reduced by over 85% within 24 hours in all three models. C3c clearance was unaffected by site or mechanism of deposit formation. C3d deposits persisted despite lack of ongoing complement activation. In passive Heymann nephritis when disease activity was monitored by urinary C5b-9 excretion, C3c was cleared in parallel with return of urine C5b-9 excretion to normal values. We conclude that glomerular deposits of C3c are cleared within 24 hours of cessation of complement activation. Positive staining for C3 utilizing antibody specific for the C3c portion documents recent complement activation usually reflecting new immune deposit formation.
Similar articles
-
Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.J Immunol. 1984 Apr;132(4):1960-6. J Immunol. 1984. PMID: 6607952
-
Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat.Kidney Int. 1989 Jan;35(1):60-8. doi: 10.1038/ki.1989.8. Kidney Int. 1989. PMID: 2651753
-
Urinary excretion of C5b-9 reflects disease activity in passive Heymann nephritis.Kidney Int. 1989 Jul;36(1):65-71. doi: 10.1038/ki.1989.162. Kidney Int. 1989. PMID: 2681928
-
Mechanisms of immune-deposit formation and the mediation of immune renal injury.Clin Exp Nephrol. 2005 Sep;9(3):183-91. doi: 10.1007/s10157-005-0357-8. Clin Exp Nephrol. 2005. PMID: 16189625 Review.
-
[Molecular pathogenesis of experimental membraneous glomerulonephritis (Heymann nephritis)].Pathologe. 1996 Jul;17(4):262-8. doi: 10.1007/s002920050164. Pathologe. 1996. PMID: 8927592 Review. German.
Cited by
-
C3-dependent effector functions of complement.Immunol Rev. 2023 Jan;313(1):120-138. doi: 10.1111/imr.13147. Epub 2022 Oct 22. Immunol Rev. 2023. PMID: 36271889 Free PMC article. Review.
-
Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.J Invest Dermatol. 2014 Feb;134(2):498-506. doi: 10.1038/jid.2013.346. Epub 2013 Aug 12. J Invest Dermatol. 2014. PMID: 23938460
-
Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice.Kidney Int. 2010 Aug;78(3):279-86. doi: 10.1038/ki.2010.132. Epub 2010 May 5. Kidney Int. 2010. PMID: 20445496 Free PMC article.
-
From Normal Skin to Squamous Cell Carcinoma: A Quest for Novel Biomarkers.Dis Markers. 2016;2016:4517492. doi: 10.1155/2016/4517492. Epub 2016 Aug 23. Dis Markers. 2016. PMID: 27642215 Free PMC article. Review.
-
Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous Nephropathy.Front Immunol. 2016 Apr 25;7:157. doi: 10.3389/fimmu.2016.00157. eCollection 2016. Front Immunol. 2016. PMID: 27199983 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous